Found: 81
Select item for more details and to access through your institution.
CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults.
- Published in:
- Human Genomics, 2012, v. 6, n. 1, p. 1, doi. 10.1186/1479-7364-6-9
- By:
- Publication type:
- Article
Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Pharmacogenetics in the evaluation of new drugs: a multiregional regulatory perspective.
- Published in:
- Nature Reviews Drug Discovery, 2013, v. 12, n. 2, p. 103, doi. 10.1038/nrd3931
- By:
- Publication type:
- Article
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Common laboratory methods in pharmacogenomics studies.
- Published in:
- American Journal of Health-System Pharmacy, 2006, v. 63, n. 21, p. 2101, doi. 10.2146/ajhp060068
- By:
- Publication type:
- Article
The Las t Poem I Write.
- Published in:
- 2022
- By:
- Publication type:
- Poem
Systematic Review of Device Parameters and Design of Studies Bridging Biologic-Device Combination Products Using Prefilled Syringes and Autoinjectors.
- Published in:
- AAPS Journal, 2020, v. 22, n. 2, p. 1, doi. 10.1208/s12248-020-0433-8
- By:
- Publication type:
- Article
Epithelial Neutrophil-Activating Peptide (ENA-78), Acute Coronary Syndrome Prognosis, and Modulatory Effect of Statins.
- Published in:
- PLoS ONE, 2008, v. 3, n. 9, p. 1, doi. 10.1371/journal.pone.0003117
- By:
- Publication type:
- Article
Pharmacogenetics of response to statins.
- Published in:
- Current Atherosclerosis Reports, 2007, v. 9, n. 3, p. 187, doi. 10.1007/s11883-007-0018-3
- By:
- Publication type:
- Article
Pharmacokinetics and CYP2D6 genotypes do not predict metoprolol adverse events or efficacy in hypertension<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 6, p. 536, doi. 10.1016/j.clpt.2004.08.020
- By:
- Publication type:
- Article
Reply<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 76, n. 2, p. 186, doi. 10.1016/j.clpt.2004.04.008
- By:
- Publication type:
- Article
β<sub>1</sub>-Adrenergic Receptor Polymorphisms and Antihypertensive Response to Metoprolol<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 44, doi. 10.1016/S0009-9236(03)00068-7
- By:
- Publication type:
- Article
The Evolving Role of Nesiritide in Advanced or Decompensated Heart Failure.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 10, p. 1266, doi. 10.1592/phco.23.12.1266.32705
- By:
- Publication type:
- Article
Intranasal Naloxone Repeat Dosing Strategies and Fentanyl Overdose: A Simulation-Based Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 1, p. e2351839, doi. 10.1001/jamanetworkopen.2023.51839
- By:
- Publication type:
- Article
Genetic and Pharmacogenetic Associations Between NOS3 Polymorphisms, Blood Pressure, and Cardiovascular Events in Hypertension.
- Published in:
- American Journal of Hypertension, 2009, v. 22, n. 7, p. 748, doi. 10.1038/ajh.2009.81
- By:
- Publication type:
- Article
Genetic Polymorphisms and Statin Therapy.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 11, p. 1302, doi. 10.1001/jama.292.11.1302-b
- By:
- Publication type:
- Article
The ICD Shock and Stress Management Program: A Randomized Trial of Psychosocial Treatment to Optimize Quality of Life in ICD Patients.
- Published in:
- Pacing & Clinical Electrophysiology, 2007, v. 30, n. 7, p. 858, doi. 10.1111/j.1540-8159.2007.00773.x
- By:
- Publication type:
- Article
NOS3 Polymorphisms Are Associated With Arterial Stiffness in Children With Type 1 Diabetes.
- Published in:
- Diabetes Care, 2007, v. 30, n. 3, p. 689, doi. 10.2337/dc06-1697
- By:
- Publication type:
- Article
CXCL5 Gene Polymorphism Association with Diabetes Mellitus.
- Published in:
- Molecular Diagnosis & Therapy, 2008, v. 12, n. 6, p. 391, doi. 10.1007/BF03256304
- By:
- Publication type:
- Article
The US Food and Drug Administration's Model‐Informed Drug Development Meeting Program: From Pilot to Pathway.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 116, n. 2, p. 278, doi. 10.1002/cpt.3228
- By:
- Publication type:
- Article
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID‐19 Under the Emergency Use Authorization.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 4, p. 890, doi. 10.1002/cpt.3191
- By:
- Publication type:
- Article
Clinical Pharmacology Approaches to Support Approval of New Routes of Administration for Therapeutic Proteins.
- Published in:
- Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 3, p. 440, doi. 10.1002/cpt.3178
- By:
- Publication type:
- Article
A Multistakeholder Perspective on Advancing Individualized Therapeutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 114, n. 5, p. 994, doi. 10.1002/cpt.3030
- By:
- Publication type:
- Article
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development – (I) A Randomized Trial with PCSK9 Inhibitors.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 71, doi. 10.1002/cpt.2769
- By:
- Publication type:
- Article
Pharmacodynamic Biomarkers Evidentiary Considerations for Biosimilar Development and Approval.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 55, doi. 10.1002/cpt.2761
- By:
- Publication type:
- Article
Model‐Based Approach to Selecting Pegfilgrastim Dose for Pharmacokinetic and Pharmacodynamic Similarity Studies in Biosimilar Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 1, p. 62, doi. 10.1002/cpt.2722
- By:
- Publication type:
- Article
Evaluating Patients With Impaired Renal Function During Drug Development: Highlights From the 2019 US FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 110, n. 2, p. 285, doi. 10.1002/cpt.2151
- By:
- Publication type:
- Article
Elucidating the Impact of Immunogenicity Assessment Postapproval: A Targeted Analysis of Immunogenicity Postmarketing Requirements and Commitments.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 3, p. 697, doi. 10.1002/cpt.2038
- By:
- Publication type:
- Article
A Systematic Assessment of US Food and Drug Administration Dosing Recommendations For Drug Development Programs Amenable to Response‐Guided Titration.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 123, doi. 10.1002/cpt.2068
- By:
- Publication type:
- Article
Regulatory Efforts to Facilitate Evaluation and Clinical Management of Drug‐Drug Interaction Risks.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 42, doi. 10.1002/cpt.1984
- By:
- Publication type:
- Article
Proceedings of a Workshop: Precision Dosing: Defining the Need and Approaches to Deliver Individualized Drug Dosing in the Real‐World Setting.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 1, p. 25, doi. 10.1002/cpt.1933
- By:
- Publication type:
- Article
Role of Guidance and Policy in Enhancing the Impact of Clinical Pharmacology in Drug Development, Regulation, and Use.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 4, p. 710, doi. 10.1002/cpt.1849
- By:
- Publication type:
- Article
Scientific and Regulatory Considerations for an Ontogeny Knowledge Base for Pediatric Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 707, doi. 10.1002/cpt.1763
- By:
- Publication type:
- Article
What's Past Is Prologue: Clinical Pharmacology at the Intersection of Science, Policy, and Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 1, p. 33, doi. 10.1002/cpt.1650
- By:
- Publication type:
- Article
An Overview of Genomic Biomarker Use in Cardiovascular Disease Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 4, p. 841, doi. 10.1002/cpt.1473
- By:
- Publication type:
- Article
Model‐Informed Drug Development: A Regulatory Perspective on Progress.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 91, doi. 10.1002/cpt.1475
- By:
- Publication type:
- Article
The US Food and Drug Administration's Model‐Informed Drug Development Paired Meeting Pilot Program: Early Experience and Impact.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 74, doi. 10.1002/cpt.1457
- By:
- Publication type:
- Article
Proceedings of a Workshop: US Food and Drug Administration‐International Society of Pharmacometrics Model‐Informed Drug Development in Oncology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 1, p. 81, doi. 10.1002/cpt.1421
- By:
- Publication type:
- Article
Considerations for Biologic Product Drug–Drug Interactions: A Regulatory Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 6, p. 1332, doi. 10.1002/cpt.1366
- By:
- Publication type:
- Article
Model‐Informed Drug Development: Current US Regulatory Practice and Future Considerations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 105, n. 4, p. 899, doi. 10.1002/cpt.1363
- By:
- Publication type:
- Article
Enrichment Strategies in Pediatric Drug Development: An Analysis of Trials Submitted to the US Food and Drug Administration.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 983, doi. 10.1002/cpt.971
- By:
- Publication type:
- Article
Transporters in Drug Development: Scientific and Regulatory Considerations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 5, p. 793, doi. 10.1002/cpt.1214
- By:
- Publication type:
- Article
Considerations for Developing Targeted Therapies in Low‐Frequency Molecular Subsets of a Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 104, n. 2, p. 282, doi. 10.1002/cpt.1041
- By:
- Publication type:
- Article
Pediatric Drug Development: Outlook for Science‐Based Innovation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 3, p. 376, doi. 10.1002/cpt.1001
- By:
- Publication type:
- Article
Mechanistic Model-Informed Proarrhythmic Risk Assessment of Drugs: Review of the 'CiPA' Initiative and Design of a Prospective Clinical Validation Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 1, p. 54, doi. 10.1002/cpt.896
- By:
- Publication type:
- Article
Perspectives on the Current State of the Biosimilar Regulatory Pathway in the United States.
- Published in:
- Clinical Pharmacology & Therapeutics, 2018, v. 103, n. 1, p. 36, doi. 10.1002/cpt.909
- By:
- Publication type:
- Article
Doxycycline alters the expression of inflammatory and immune-related cytokines and chemokines in human endometrial cells: implication in irregular uterine bleeding.
- Published in:
- Human Reproduction, 2006, v. 21, n. 10, p. 2555, doi. 10.1093/humrep/del206
- By:
- Publication type:
- Article
Multimarker Approach Predicts Adverse Cardiovascular Events in Women Evaluated for Suspected Ischemia: Results from the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation.
- Published in:
- Clinical Cardiology, 2009, v. 32, n. 5, p. 244, doi. 10.1002/clc.20454
- By:
- Publication type:
- Article
Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril Study (INVEST).
- Published in:
- Clinical Cardiology, 2005, v. 28, n. 7, p. 321, doi. 10.1002/clc.4960280704
- By:
- Publication type:
- Article